Product Description
Methotrexate was originally developed and continues to be used for chemotherapy, either alone or in combination with other agents. It is effective for the treatment of a number of cancers, including: breast, head and neck, leukemia, lymphoma, lung, osteosarcoma, bladder, and trophoblastic neoplasms.Highly Pure Methotrexate for Pharmaceutical FormulationsMethotrexate API, medicine grade, boasts a purity of 99%, making it ideal for pharmaceutical applications. Its yellow crystalline powder form ensures ease of handling during the manufacturing process. Used primarily in chemotherapy, it supports a range of treatment protocols due to its effectiveness and versatility. With stringent quality standards, the product meets industry demands for safety and potency.
Reliable Shelf Life and Stable StorageDesigned for long-term use, Methotrexate API offers a shelf life of up to 5 years when stored appropriately. This extended stability allows manufacturers and distributors to maintain inventory efficiently, minimizing wastage and ensuring ongoing supply for critical medical needs. Proper storage is vital to retain optimal efficacy throughout its usable lifespan.
Versatile Usage in Cancer TreatmentMethotrexate serves as a foundational compound in chemotherapy regimens. It can be administered alone or in combination with other agents, enhancing therapeutic effects. Its reliable action in targeting rapidly dividing cells makes it a staple in oncology pharmaceuticals, supporting patient treatment plans across a variety of cancer types.
FAQ's of Methotrexate Api:
Q: How is Methotrexate API typically used in pharmaceutical manufacturing?
A: Methotrexate API is primarily utilized as a pharmaceutical intermediate in the production of chemotherapeutic medicines. Owing to its high purity and reliable physical properties, it serves as a base ingredient for formulating injectable, tablet, and combination therapies for cancer treatment.
Q: What are the key benefits of using Methotrexate in chemotherapy?
A: Methotrexate is highly valued for its effectiveness in inhibiting the growth of rapidly dividing cells, a characteristic of many cancers. Its versatility allows it to be used either on its own or as part of combination therapy, improving outcomes and providing flexibility in oncological treatment protocols.
Q: When should Methotrexate API be stored and handled to maintain its efficacy?
A: Methotrexate API should be stored in a cool, dry environment, away from direct sunlight and moisture. Following proper storage recommendations ensures the product retains its 99% purity and effectiveness for its full 5-year shelf life.
Q: Where can Methotrexate API be sourced for pharmaceutical production?
A: Methotrexate API is available from authorized exporters, suppliers, and traders in India. These vendors ensure compliance with pharmaceutical regulations and maintain high standards for purity and safety.
Q: What is the physical form and appearance of Methotrexate API, and why does it matter?
A: Methotrexate API is supplied as a yellow crystalline powder, which is advantageous for precise measurement, consistent blending, and ease of dissolution in manufacturing processes. The physical characteristics contribute to reliable quality in final pharmaceutical products.
Q: What is the process involved in incorporating Methotrexate API into medicines?
A: Methotrexate API is carefully measured and blended with excipients before being processed into the desired pharmaceutical form, such as tablets or injectables. Stringent protocols are followed to ensure dosage accuracy and product stability throughout the manufacturing process.